| Ruth Gray, | |
|
11245 Huron St, Westminster, CO 80234-2806 | |
| (303) 457-6218 | |
| Not Available |
| Full Name | Ruth Gray |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 11245 Huron St, Westminster, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972709186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 27097 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ruth Gray, 980 Explorador Calle, Denver, CO 80229 Ph: () - | Ruth Gray, 11245 Huron St, Westminster, CO 80234-2806 Ph: (303) 457-6218 |
News Archive
A skin patch treatment for a common type of skin cancer called basal cell carcinoma effectively destroys facial tumors in most patients without the need for surgery or major radiation, researchers report.
Deaths from opioid use in Ontario have doubled-from 13.7 deaths per million residents in 1991 to 27.2 deaths per million residents in 2004-according to a new study led by physicians at St. Michael's Hospital and the Institute for Clinical Evaluative Sciences (ICES) in Toronto.
The Innovation Center of NanoMedicine (Director General: Prof. Kazunori Kataoka, Location: Kawasaki in Japan, Abbreviation: iCONM) reported in ACS Nano (Impact Factor: 14.588 in 2019) together with the group of Prof. Yu Matsumoto of Otorhinolaryngology and Head and Neck Surgery (Prof. Tatsuya Yamasoba) and the group of Prof. Horacio Cabral of the Department of Bioengineering (Prof. Ryo Miyake) in the University of Tokyo that the efficacy of polymeric nano-micelles with different drug activation profile depends on the expression level of c-Myc, one of the major proto-oncogene, has been developed.
Pfizer Inc. announced today its investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the United States Food and Drug Administration for the potential treatment of patients with breast cancer.
A new research study demonstrates that a single chemical growth factor orchestrates a complex developmental process by sequentially activating distinct subsets of molecular signals.
› Verified 6 days ago
Diane Wieland, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11245 Huron St, Westminster, CO 80234 Phone: 303-743-5855 | |
Morgan Dillingham, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11245 Huron St, Westminster, CO 80234 Phone: 303-457-6666 | |
Virginia R Thomas, PA-C Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1499 W 120th Ave, Suite 230, Westminster, CO 80234 Phone: 303-920-5161 Fax: 303-452-4625 | |
Audrey Camacho, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11245 Huron St, Westminster, CO 80234 Phone: 303-657-6666 | |
Helen Bolyard, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11245 Huron St, Westminster, CO 80234 Phone: 303-457-6166 | |
Mary Romero, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11245 Huron St, Westminster, CO 80234 Phone: 303-743-5855 | |
Jill M Gould, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11246 Quivas Loop, Westminster, CO 80234 Phone: 937-765-1997 |